Hogan Lovells advises Shop Apotheke on initial public offering

Hogan Lovells has advised Shop Apotheke Europe N.V. on its initial public offering. 

Shop Apotheke Europe N.V. is one of the leading online pharmacies in Continental Europe focused on non-prescription, over-the-counter ('OTC') medication and pharmacy-related beauty and personal care ('BPC') products. The Company operates in Germany, Austria, France, Belgium, Spain, Italy and the Netherlands.

The offer consists of up to 3,571,428 newly issued shares from a capital increase of the company. Additionally, investors may be allotted another 535,714 shares of a securities loan ("Greenshoe shares") in the context of an over-allotment option.

The shares are being offered to private and institutional investors from 29th September until approximately 11th October. The price range within which offers to purchase may be submitted is between €28 and €35. The final issue price will be determined at the end of the offer period by means of a book building process. On the basis of the price range and envisaged gross proceeds of the Company of €100m, the sale of all offer shares from the capital increase and full exercise of the over-allotment option, the volume of the offering will amount to between €115m and €118m, approximately.

The shares of Shop Apotheke Europe N.V. are expected to be traded on the regulated market and the sub-segment of the regulated market with additional post-admission obligations (Prime Standard) of the Frankfurt Stock Exchange as of 13 October 2016. The securities prospectus for the public offering and the admission of the shares of Shop Apotheke Europe N.V. to trading has been approved by the Dutch Authority for the Financial Markets (AFM) and notified to the German Federal Financial Supervisory Authority (BaFin) on 28 September.

Hogan Lovells for Shop Apotheke


Prof. Dr. Michael Schlitt (Partner), Dr. Susanne Lenz (Counsel), Thomas Poss (Senior Associate), Sebastian Seibold (Associate), Nona Naydenova (Projects Associate), Walter Andert (Projects Associate), Christian Schröder (Corporate/Capital Markets);

Tim Wybitul (Partner), Jana Bruns (Litigation, Arbitration and Employment).


Dr. Lutz Angerer (Partner, Corporate/Corporate Transactional);

Dr. Jörg Schickert (Partner), Arne Thiermann (Counsel, Corporate/Commercial).


Dr. Heiko Gemmel (Partner), Anne-Svenja de Kiff (Associate, Corporate/Tax).


John Basnage (Partner), Oliver Reimers (Associate), Mary Ma (Associate, Corporate/US-Law).


Victor de Vlaam (Partner), Johannes Buntjer (Partner), Marten Schellingerhout (Counsel), Peter Stokking (Counsel), Aafke Pronk (Senior Associate), Leonie Huisman (Senior Associate), Chantalle Schoegje (Associate, Corporate/Corporate Transactional).


Gemma Hall (Corporate/Corporate Transactional).

Back To Listing